Destiny Tech100 (DXYZ): A Long-Term Owner's View

The cost structure, by contrast, is clear: management fees, audit/tax, legal, valuation, compliance, and administrative costs are fixed and semi-fixed and run heavy; this is not a light-fee platform that automatically generates meaningful operating leverage as it scales, at least not yet. In 2025, management fees were $3.525 million, audit and tax fees were $1.2409 million, and legal fees were $1.1272 million.

This business depends very heavily on a handful of factors: it relies on the private secondary market and SPV supply, on the advisor team's deal network, on the financing environment for private companies and the IPO/exit window, and on the quarterly valuation framework, and it carries clear key-person risk as well. The company writes it bluntly in its latest offering materials: the core of the advisor's investment professional team today is essentially Sohail Prasad, and the advisor previously had no experience managing a registered closed-end fund.

If the stock market closed for five years, would I be willing to hold this business? Only at or below NAV would I be grudgingly willing; at the current large premium, I would not. The reason is simple: with the market closed, what you are left holding is a high-fee, low-cash-distribution pool of private technology assets dependent on future exit events, not a business machine that steadily produces cash.

Business understandability score: 2/5. I can understand the "wrapper" itself, but it is hard to understand its underlying economic engine the way I understand Coca-Cola or Mastercard, that is, how it will keep sending cash to shareholders.

Industry and Competitive Landscape

The "industry" DXYZ operates in is, more precisely, the vehicle space for accessing private technology assets through public markets. Long-term demand is not absent: many investors genuinely want pre-IPO access to late-stage private companies such as Anthropic, SpaceX, and OpenAI. The company's website also positions it as a listed portfolio that "gives ordinary investors first-time access to these private-market leaders."

But this is a space highly influenced by the technology cycle, interest rates, primary-market valuations, the activity level of secondary private transactions, the IPO window, and the regulatory environment. The company itself acknowledges that many of its investments are private, restricted, illiquid securities, and that investment returns depend heavily on these companies' operational success or failure over the coming years and on capital-market conditions.

There are not many close comparables, but at least a few directions exist. The first is a listed vehicle like SuRo Capital that likewise offers public-market access to private growth companies; SuRo's NAV as of March 31, 2026 was $14.24 per share, its latest price about $14.23 per share, trading essentially around NAV. The second is a 40 Act product like ARK Venture Fund, not exchange-traded but likewise offering private technology exposure, whose latest publicly disclosed net expense ratio is about 2.90%, gross expense ratio 3.49%, with a subscription/redemption mechanism closer to trading at NAV. The third is the strongest substitute of all, the low-fee broad-based index ETF, for example IVV with an expense ratio of about 0.03%.

DXYZ's current industry position is more like a capital container with "the strongest scarcity narrative but not necessarily the strongest structural quality." As of March 31, 2026, the company held only 36 positions against a target of 100, and the holdings are highly concentrated in AI and aerospace; the top economic exposures include Anthropic at 18.1%, SpaceX at 14.5%, and OpenAI at 5.8%, plus a 31.4% cash/money market position. This is not a mature, balanced, low-volatility asset pool.

This industry's "profit pool" is not as concentrated and clear as that of consumer goods or exchanges; it is more the joint product of market sentiment, the narrative of scarce assets, and capital demand. DXYZ has no real "pricing power" either; what it can do is sell new shares when the stock price exceeds NAV, converting the high price the market gives it into NAV accretion for existing shareholders. That move is clever, but it is not a durable moat.

Industry attractiveness score: 2/5. The underlying private technology assets may be enticing, but as a "vehicle for public investors to enter these assets," this space is unfriendly to the conservative value investor.

Moat and Management

Moat Analysis

Broken down item by item through a Buffett-style moat framework, the conclusions for DXYZ are not encouraging.

Brand advantage: weak. DXYZ does command significant market attention, especially because it became famous for its extreme discount/premium swings, but that is more "attention" than a brand that reliably converts into higher ROIC.

Cost advantage: none. This fund's current total expense ratio is about 4.56%, with an actual 2025 expense ratio of 4.53%, which is not cheap relative to substitute products offering private growth exposure, and is nowhere near the 0.03% of a broad-based ETF.

Scale advantage: limited. Scale itself has not meaningfully pushed fees down; in fact, management fees are charged on total assets. The biggest benefit of scale is not operating efficiency but the ability to do larger premium issuance when the market is willing to award a high premium. That benefits existing shareholders, but it still does not constitute a durable competitive advantage.

Network effect: none. More investors do not make the fund's product itself better, nor do they create network externalities like those of Visa, Microsoft, or Google.

Switching costs: almost none. Investors can buy and sell on the secondary market at any time, or choose substitutes like SuRo, ARKVX, or index ETFs.

Distribution advantage: a little, but not solid. The company emphasizes that it sources opportunities through its advisor network, the private secondary market, SPVs, and broker sources, and it does manage to access some scarce names. But the company also acknowledges that related parties have no obligation to keep providing it with opportunities, and that competitors are often larger and better resourced.

Patents, licenses, regulatory barriers: weak. Status as a 40 Act registered fund does bring compliance costs, but it is not an exclusive passport, much less a scarce barrier like an exchange license.

Data advantage: weak. The company references secondary-market prices, research firms, and third-party information, but it admits that in private secondary transactions it often cannot obtain complete information.

Culture and operating capability: insufficient evidence. There is currently no verifiable long-term operating-culture compounding of the Berkshire, Danaher, or Costco kind. A more realistic assessment: it is a newly launched investment vehicle, not a capital-allocation machine proven over time.

Capital allocation capability: moderate, but dependent on the market environment. The most commendable action in 2025 was the ATM issuance the company carried out when its share price was well above NAV. That objectively created NAV accretion for existing shareholders: of the 2025 increase in NAV per share, roughly 73.8% came from premium issuance. But this is not a capability that can be replicated every year; it is the ability to exploit market mispricing. Once the premium disappears, this "advantage" rapidly weakens.

Moat strength score: 1/5. This is more a "public container holding some hot private technology stocks" than a high-quality business with a durable competitive advantage.

Management and Capital Allocation

Is management honest, rational, and long-term oriented? At this stage one can only give partial credit. On one hand, management is not vague about risk disclosure in the prospectus, clearly warning that the share price is highly volatile, that the investment is highly speculative, and that a closed-end fund's share price can diverge far from NAV. On the other hand, the fees it charges are still on the high side, and the strategy and results have not yet been through a full cycle.

On alignment of interests, CEO Sohail Prasad beneficially owned about 711,190 shares in total as of October 13, 2025, roughly 5% of the shares outstanding at the time; at the end of 2025, the portfolio manager's beneficial interest in the fund was disclosed in the dollar range of over $1 million. This indicates it is not "zero skin in the game," but it is not extremely strong alignment either.

On capital allocation, the action most valuable to existing shareholders is indeed premium issuance. In 2025 the company sold 11,096,400 shares through the ATM at a weighted-average price of $29.48 per share, raising about $324 million net; in Q1 2026 it sold another 8,489,359 shares at a weighted-average price of $28.76 per share. The "net proceeds of about $24.1 million" given in that filing for the latter clearly does not match shares times price, raising the possibility of a disclosure-convention or typesetting error, so I will not treat that net figure as high-confidence data, but the share count and price themselves at least show the company continuing to raise capital by exploiting the high premium.

On buybacks, there were none. The 2025 report disclosed that the company and affiliated purchasers did not repurchase company stock. For a closed-end fund that at times trades near NAV, this means there is as yet no evidence that management treats "secondary-market discount/premium management" as a mature tool for long-term use.

Governance has two sides. On the positive side, the 2025 annual report was audited by KPMG with an unqualified opinion, and in the 2025 N-CSR management also stated that disclosure controls were effective. On the negative side, in 2024 the company disclosed a material internal control weakness: for certain investments held through SPVs, it lacked adequate controls to obtain and evaluate underlying financial information. The company now says this has been remediated, but such history reminds us that this is not an asset-management vehicle that can be described as "extremely simple and extremely transparent."

There is also a fact that cannot be ignored: the company itself acknowledges that the advisor team previously had no experience managing a registered closed-end fund, and that the investment team is highly reliant on key individuals. For shareholders who understand and use complex private-asset structures, this is not a fatal flaw, but for conservative investors it raises the "trust hurdle" significantly.

Management and capital allocation score: 3/5. I am willing to grant that it has been rational about "issuing shares while the premium is high to accrete existing shareholders' NAV"; but I do not yet see a long-term, low-fee, replicable capital-allocation record that would justify a higher score.

Financial Quality and Owner Earnings

Financial Quality Analysis

First, it must be said: DXYZ has operated since 2021 and began listed trading in March 2024, so its history is very short, and one cannot study a full 5-to-10-year financial cycle the way one can for a mature listed company. Second, many traditional operating metrics, such as gross margin, operating margin, ROIC, and capital-expenditure intensity, simply do not apply to a closed-end fund holding financial assets, or matter far less than they would for an industrial, consumer, or software company.

The table below is compiled from the company's disclosed annual reports, financial highlights, and the March 31, 2026 supplemental disclosure, focusing on NAV, net investment income, expense ratio, share-count changes, and the cash and portfolio structure.

There are four most important financial judgments.

First, accounting profit and cash profit do not match. In 2025 the company's "net increase in net assets from operations" was $44.232 million, the core driver being $54.3977 million of unrealized fair-value change gains; but net investment income for the year was -$6.185 million, and realized investment losses were -$3.9807 million. In other words, it looks profitable on paper, but on a cash basis no stable, real, freely distributable profit has been generated.

Second, growth is highly dependent on external capital rather than internal cash flow. In 2025 net cash outflow from operating activities was about $319 million, while net cash inflow from financing activities was about $324 million, very nearly "raising and deploying at the same time." This is not unreasonable within a fund structure, but it shows that DXYZ does not grow by rolling up its own cash flow; it grows by issuing more shares when the capital market is willing to award it a high valuation.

Third, the balance sheet is not currently fragile, but leverage could be added in the future. At the end of 2025, total liabilities were only $3.3232 million, with no apparent current debt pressure; the latest offering materials also state that within the first 12 months after the registration statement, the company does not intend to borrow or issue preferred stock/debt. But the company also explicitly reserves the possibility of using leverage in the future, and once leverage is employed, NAV volatility will be amplified.

Fourth, the change in share count is very large. During 2025 shares outstanding rose from 10.8799 million to 21.9763 million; in Q1 2026 another 8.4894 million were sold. This is not "quiet dilution" but a public, rational exploitation of the premium to issue shares; for existing shareholders it is accretive, while for new shareholders it means you must look carefully at whose accretion you are buying into when you enter.

From a "downside survivability" standpoint, the fund level is currently acceptable: there is no heavy leverage, and as of March 31, 2026 it still held a 31.4% money market fund position. The question is not "will it survive," but "will shareholders, while it survives, also suffer long-term low returns or even permanent loss."

Owner Earnings Analysis

To do Owner Earnings for DXYZ, I must first be honest: the standard Buffett-style Owner Earnings framework is distorted here. Because DXYZ does not make money by selling goods, collecting receivables, maintaining capacity, and reinvesting for expansion through operating activity; it is a fund holding financial assets. Its true economic value comes from future exits, refinancings, mergers and acquisitions, IPOs, improved secondary liquidity, and the process by which these events are mapped into NAV.

If I still insist on doing a conservative Owner Earnings, I would handle it as follows:

• Start from 2025 net investment income of -$6.185 million, because it represents the result closest to "recurring cash earnings minus recurring expenses."

• Do not include the unrealized gain of $54.3977 million, because it is not distributable cash.

• Maintenance capital expenditure for the fund itself can be treated as nearly zero, but this does not mean that "reinvestment" is economically unnecessary; it simply takes the form of buying new financial assets, not factory CAPEX.

• If we further include the 2025 realized investment loss of $3.9807 million, then the more conservative "true distributable earnings" actually come out on the order of about -$10.16 million.

Therefore, my conclusion on DXYZ is: so far it has not proven it can produce positive, stable, truly distributable Owner Earnings over the long term. It is more like a collection of call options on the future exit value of private technology assets, plus a high-fee, listed wrapper layer.

"How many times Owner Earnings is the current valuation?" Strictly speaking, it is meaningless, because on a conservative basis its current Owner Earnings are negative. For this kind of name, what should truly be anchored on is NAV and its realizability, not PE or P/FCF.

Valuation and Margin of Safety

The current share price is as follows. DXYZ's latest quoted price is about $40.43.

Intrinsic Value Estimation

Owner Earnings Discount Method

Because DXYZ has no positive Owner Earnings in the normal sense, I adopt the substitute method of "taking the latest NAV as the starting point, assuming net NAV compounds over the long term, and discounting back to today." This method is not perfect, but it is closer to its essence than directly taking accounting profit or a P/E multiple. The starting point uses the company's latest disclosed NAV of $24.56 per share; the expense hurdle uses the currently disclosed 4.56% total expense ratio as a realistic constraint.

My scenario assumptions are as follows, all of which are analytical assumptions, not company guidance:

These results mean that even under a very optimistic assumption for the portfolio's long-term net growth, the current intrinsic value is only close to the current price, not significantly above it; and under the neutral and conservative scenarios, the current price is clearly expensive.

If you back out the annualized return over the next 10 years from a purchase today at $40.43, the above assumptions correspond roughly, respectively, to:

• Conservative scenario: about -0.2% per year.

• Neutral scenario: about 4.7% per year.

• Optimistic scenario: about 9.5% per year.

For a high-volatility, low-transparency private technology fund with a relatively high share of Level 3 valuation, this return distribution is not enticing for a conservative investor.

Relative Valuation Method

The most useful metrics for relative valuation here are not PE, but price relative to NAV and expense ratio.

• DXYZ's current price of about $40.43, relative to the latest disclosed NAV of $24.56, is about 1.65x P/NAV.

• SuRo Capital's current price is about $14.23, while its March 31, 2026 NAV was $14.24 per share, essentially trading at NAV.

• ARK Venture Fund's latest publicly disclosed net expense ratio is about 2.90%, gross expense ratio about 3.49%, clearly lower than DXYZ's latest disclosed 4.56%.

• As the most basic substitute, IVV has an expense ratio of about 0.03%.

This shows that the price the market currently awards DXYZ is not only far above its latest NAV, but also clearly above peer public vehicles where "similar asset exposure can trade near NAV or even at a discount." Put another way, much of what you pay now is not the value of the assets themselves, but a scarcity narrative and a trading premium.

Asset Value and Liquidation Value Method

For a structure like DXYZ, the asset value method is the primary method. As of March 31, 2026, the company disclosed NAV per share of $24.56, with a portfolio of about $742.5 million, of which 31.4% is money market funds and the rest is private technology stocks, SPVs, forward contracts, PPUs, convertible bonds, and the like. The company also clearly warns that many assets have no active market and that valuations are quarterly fair-value judgments made under board-approved procedures, with inherent subjectivity.

Therefore, I will not award a large premium above NAV. On the contrary, I believe liquidation value is more likely to fall below NAV, because private assets, SPVs, forward contracts, and holding restrictions mean that "fair value on the statements" does not equal "the money I could actually get back if I went to sell today." The company itself acknowledges that, if forced to liquidate quickly, it might sell well below carrying value.

A very intuitive piece of arithmetic: about $7.71 per share of the current latest NAV corresponds to money market funds; if you buy in at the current $40.43, you are buying even the cash position at a significant premium. Going further, if you first deduct this cash portion at face value, the market is effectively pricing the remaining non-cash portfolio at about 1.94x its latest carrying value. For a conservative investor, that leaves almost no margin of safety.

Margin of Safety Judgment

Is the current price cheap enough: no. The most fragile valuation assumption is not whether Anthropic will succeed or whether SpaceX is worth some sky-high price, but: whether the market will keep awarding DXYZ a significant premium above NAV over the long term. As long as this assumption does not hold, shareholder returns will be clearly impaired.

If future growth falls short of expectations, or the expense ratio stays around 4% to 5% over the long term, investors can easily end up with "the underlying companies may be fine, but fund shareholder returns are mediocre." If the valuation multiple reverts from the current roughly 1.65x NAV to 1.0x NAV, then with NAV unchanged, the theoretical downside in the share price is close to 39%. Add an underlying valuation markdown on top, and the decline would be larger.

This therefore looks very much like a classic case of a "good asset class but a bad price." It is not without appeal; it is simply unfriendly to the buyer at the current price. My judgment is: it is worth waiting for a better price, rather than talking yourself into it at the current one.

My valuation range is as follows:

• Conservative intrinsic value range: $13 to $20 per share. This corresponds to applying a discount to NAV, reflecting Level 3, SPV, fee, and exit uncertainty.

• Fair intrinsic value range: $20 to $26 per share. This roughly corresponds to being near the latest NAV but awarding no significant premium.

• Optimistic intrinsic value range: $26 to $39 per share. This is built on higher long-term net growth and some terminal-value premium.

On that basis, the operating ranges I give are:

• Ideal buy price: $18 to $24 per share.

• Acceptable holding price: $24 to $30 per share.

• Clearly overvalued price: above $35 per share.

All of these ranges should be rolled forward in step after the company's next NAV update, because DXYZ's NAV is updated quarterly rather than daily.

Data Limitations

Three points must be noted. First, the latest public NAV anchor is $24.56 per share as of March 31, 2026, not a real-time NAV. Second, in the company's May 11, 2026 supplemental disclosure, the Q1 ATM "shares times average price" and "net proceeds" are clearly arithmetically inconsistent, which I treat as a disclosure item requiring further verification. Third, because DXYZ is an investment company rather than an operating company, traditional valuation metrics such as PE, EV/EBITDA, ROIC, and FCF have very weak explanatory power.

Risks, Comparisons, and Checklist

Risks and the Strongest Bear Case

The most important risk is not short-term volatility, but the following categories of permanent capital loss risk.

Competition and deal-sourcing risk. The company itself acknowledges that competitors are often larger and better resourced, and that related parties have no obligation to keep providing it with investment opportunities. If it cannot access good deals, future returns will be devoured by high fees.

Technology and underlying-asset distortion risk. The company allocates heavily to AI and aerospace, a strong theme, but also one more prone to valuation drawdowns during a round of declining risk appetite or a weakening financing environment. As of March 31, 2026, the company's largest single economic exposure was Anthropic at 18.1%, with SpaceX totaling about 14.5%, a concentration that is not low.

Regulatory and structural risk. DXYZ makes heavy use of SPVs, forward contracts, restricted shares, and PPUs. The company clearly states that for many SPVs it has no control and no voting rights, and that these structures may carry different fees, withdrawal restrictions, and compliance risks.

Leverage risk. Current leverage is low, but the filings explicitly reserve the possibility of future borrowing, debt issuance, and preferred-stock issuance; once that happens, both NAV and market-value volatility will be amplified.

Management and key-person risk. The advisor team relies on a few core individuals and previously had no experience managing a registered closed-end fund.

Valuation and accounting risk. The company itself acknowledges that the quarterly fair-value valuation of private assets is subjective; in 2024 it also disclosed a material weakness in the control over obtaining SPV underlying information, though it stated controls were effective in 2025.

The strongest bear case can really be distilled into one sentence: DXYZ is not a high-quality operating company but a market-overvalued private technology asset wrapper; when the premium disappears, shareholders may simultaneously suffer "a markdown in underlying asset valuations" and "the deflation of the fund wrapper's premium," a double blow.

What facts would make me admit I was wrong? If the following occur over the next few years, I would raise my view: the company can keep growing NAV per share steadily and at high quality without relying on extreme premium issuance; it achieves multiple large, verifiable, successful exits; the expense ratio falls markedly; and the market stabilizes its long-term trading price near NAV while NAV growth is sufficiently high. Conversely, if a core holding suffers a sharp markdown, the premium vanishes quickly, cash sits undeployed for a long time, key people leave, or the company begins to lever up under unfavorable conditions, I would shift further toward the pessimistic.

The worst permanent-capital-loss scenario is a 30% to 50% downward revision of underlying private technology valuations, combined with DXYZ shifting from premium to discount trading. In that case, even if the fund itself survives, shareholders' permanent loss could exceed half. This risk is not alarmist; it is jointly determined by "high fees + highly subjective valuations + high premium + high thematic concentration."

Comparison with Other Opportunities

Compared with SuRo Capital, DXYZ does not have an exclusive advantage in asset class: both let public markets access private growth companies, but SuRo currently trades roughly at NAV, while DXYZ is still significantly above NAV. For a long-term buyer, the difference in entry price is itself the difference in return.

Compared with a broad-based index ETF, DXYZ's core problem is even more apparent. IVV has an expense ratio of about 0.03%, with high transparency, daily pricing, strong liquidity, and far greater diversification than DXYZ; whereas DXYZ's latest total expense ratio is about 4.56%, its NAV is updated quarterly, and it holds a large amount of Level 3 private assets with 31.4% still in money market funds. When you buy DXYZ, what you get is a fantasy of higher odds, while also buying higher opacity and a heavier fee drag.

Compared with the 10-year U.S. Treasury, the comparison today is not absurd either. FRED shows the 10-year Treasury yield was around 4.46% in early June 2026. Under my neutral scenario for DXYZ, the expected annualized return from the current share price is roughly 4.7%, barely above the risk-free rate, yet it bears far higher valuation and liquidity risk.

So, if the question is "is buying it clearly superior to buying the index?" my answer is: no clear advantage. If the question is "is its expected return sufficient to compensate for the risk?" my answer is: at the current price, no. If the question is "if I could hold only 5 assets, does it deserve a slot?" my answer is: it does not.

Investment Checklist

• Can I understand this business: Pass, but what I understand is the fund wrapper, not the underlying economic engine.

• Does it have stable long-term demand: Uncertain. There is demand for private technology exposure, but demand for any single closed-end fund wrapper is unstable.

• Does it have a durable moat: Fail.

• Does it have pricing power: Fail. Its trading price comes from market sentiment, not operating pricing power.

• Can it produce stable free cash flow: Fail.

• Is its return on capital excellent: Uncertain. Currently it is reflected mostly in NAV-per-share accretion from premium issuance.

• Is management trustworthy: Uncertain. There is share ownership and clear risk disclosure, but the history is too short.

• Is capital allocation rational: Pass, but mainly for existing shareholders.

• Is the balance sheet sound: Pass. Current liabilities are low and the cash position is high.

• Is the valuation below intrinsic value: Fail.

• Is the margin of safety sufficient: Fail.

• Does long-term holding let me rest easy: Fail.

• What key facts would make me sell: A premium collapse, markdowns of core holdings, a long-term high cash drag, key-person changes, fees staying high.

• Do I just want to buy because the price has risen or because of market sentiment: Very possibly. DXYZ's historical market-price performance has been far more extreme than its NAV.

Final Investment Conclusion

【Final Rating】 Avoid

【One-Sentence Investment Thesis】 DXYZ offers scarce private technology asset exposure, but buying at the current price is essentially paying a high price for a high-fee fund wrapper with subjective valuations and a significant premium to net assets, rather than buying at a reasonable price an excellent business that keeps producing cash.

【Core Bull Case】

• The underlying assets are genuinely scarce, including private technology exposure to Anthropic, SpaceX, OpenAI, and others that public markets cannot directly access.

• Management has, while at a high premium, issued shares through the ATM, creating clear NAV-per-share accretion for existing shareholders.

• At the fund level there is currently no apparent heavy leverage pressure, and as of March 31, 2026 it still held a 31.4% money market fund position, with stronger survivability than a high-leverage structure.

• As a registered closed-end fund under the 1940 Act, it is more tradable for ordinary investors and has a more familiar legal structure than directly participating in private SPVs.

【Core Bear Case】

• The current share price is at a premium of about 64.6% to the latest disclosed NAV, with a clearly insufficient margin of safety.

• 31.4% of the latest assets is still money market funds, and you are paying a high premium for the cash position.

• The bulk of 2025 NAV-per-share growth came from premium issuance, not from repeatable economic returns generated by the underlying investments themselves.

• The expense ratio is high and 2025 net investment income was negative, indicating that no real, distributable cash-flow engine has yet been formed.

• A large share of the underlying assets is Level 3, SPVs, restricted shares, and forward contracts, with high valuation subjectivity and liquidity risk.

【Key Assumptions】

• The latest disclosed NAV is broadly close to the assets' true realizable value.

• Management can keep deploying subsequently raised capital into high-quality, reasonably priced private technology names.

• The market will not quickly pull DXYZ's long-term pricing back from a high premium to near NAV or even a discount.

• The high expense ratio can ultimately be covered by sufficiently high underlying net growth.

【Fair Buy Price】 $18 to $24 per share. This range is given on the principle that the price "should at least be near the latest NAV, and ideally at a discount"; given DXYZ's Level 3 valuations, liquidity discount, fee drag, and shareholder returns that are extremely sensitive to the premium, I am unwilling to give it a value-investing buy point at a level clearly above NAV.

【Target Holding Period】 If the price returns to the reasonable range in the future and the investment logic holds, the holding period should be considered at 10 years or more; but at the current price, I would not treat it as a core asset that can be locked away with confidence for 10 years.

【Expected Annualized Return】 Calculated from the current price of about $40.43, under the 10-year scenarios I set:

• Conservative scenario: about -0.2% per year.

• Neutral scenario: about 4.7% per year.

• Optimistic scenario: about 9.5% per year.

This return distribution is not enough to make me bear such high valuation and structural risk for it today.

【Maximum Loss Risk】 If private technology valuations clearly pull back and DXYZ shifts from premium trading back to discount trading, a 50% to 70% share-price loss is not unimaginable. Such a loss would largely be permanent, because it could come both from a shrinkage of the underlying assets and from the deflation of the fund wrapper's premium.

【Tracking Metrics】

• The latest NAV per share and the sources of NAV change.

• The premium/discount level of the share price relative to NAV.

• Whether new share issuance continues to be completed at prices above NAV.

• When, and at what price, the 31.4% money market fund position is deployed.

• Whether the top five holdings become further concentrated.

• Whether realized exit gains begin to replace unrealized fair-value gains.

• Whether the total expense ratio declines.

• Whether key individuals and the advisor/board undergo significant changes.

• Whether internal controls and valuation disclosure remain sound.

• Whether the major private secondary market and the IPO window improve.

【Signals That Trigger Re-evaluation】

• The share price falls to near or below the latest NAV.

• The next NAV update shows a markdown clearly below expectations.

• Management stops, or is unable to continue, issuing shares at levels above NAV.

• A long-term high cash position cannot be deployed.

• The valuation logic for core holdings such as Anthropic, SpaceX, and OpenAI changes materially.

• The expense ratio rises, leverage increases, or governance deteriorates.

• Key individuals depart.

【Final Recommendation】 Put plainly, the most appealing thing about DXYZ is "what it holds," not "what it is." For long-term value investors, these two must be kept separate. The underlying assets can be remarkable, but the purchase price of the fund wrapper equally determines the outcome. At today's price, I see neither a sufficient margin of safety nor a sufficiently certain path to cash returns. The better approach is not to chase its scarcity narrative, but to wait: wait for the updated NAV, wait for the discount/premium to return to reason, and wait for a moment that looks more like "buying assets" than "buying sentiment."

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.